cro.directory
← Compare landing

AMSbiopharma vs iFyber, LLC

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/amsbiopharma/ifyber

CategoryAMSbiopharmaiFyber, LLC
Listed sitecrocro
SummaryAnalytical CRO providing comprehensive analytical services for drug research, preclinical development, and quality control across pharmaceutical and biopharmaceutical industries.Preclinical CRO providing custom method development, antimicrobial efficacy and biofilm testing, LC-MS/MS analysis, and in vitro biocompatibility studies for R&D teams. Work spans biology, chemistry, and materials science.
Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Preclinical In Vitro Studies
  • Microbiology Services
  • Preclinical In Vitro Studies
  • Pathology & Histology Services
  • Analytical Method Development & Validation
  • Proteomics Services
  • Biomarker Assays
  • Genomics & Sequencing Services
  • Flow Cytometry Services
ModalitiesData not yet provided.Data not yet provided.
IndicationsData not yet provided.Data not yet provided.
LocationsData not yet provided.
  • Headquarters, Ithaca, New York, United States
Certifications
  • AENOR · Identifier: UNE-EN ISO 14001:2015
  • IQNET · Identifier: IQNET
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.